Quanterix Corporation (NASDAQ: QTRX) announced that Anthem Blue Cross and Blue Shield will begin covering blood-based biomarker testing for Alzheimer's ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA